Effect of roflumilast on inflammatory cells in the lungs of cigarette smoke-exposed mice

Springer Science and Business Media LLC - 2008
P. A. Martorana1, Benedetta Lunghi1, Monica Lucattelli1, Giovanna De Cunto1, Rolf Beume2, Giuseppe Lungarella1
1Department of Physiopathology and Experimental Medicine, University of Siena, Siena, Italy
2Nycomed GmbH, Konstanz, Germany

Tóm tắt

Abstract Background We reported that roflumilast, a phosphodiesterase 4 inhibitor, given orally at 5 mg/kg to mice prevented the development of emphysema in a chronic model of cigarette smoke exposure, while at 1 mg/kg was ineffective. Here we investigated the effects of roflumilast on the volume density (VV) of the inflammatory cells present in the lungs after chronic cigarette smoke exposure. Methods Slides were obtained from blocks of the previous study and VV was assessed immunohistochemically and by point counting using a grid with 48 points, a 20× objective and a computer screen for a final magnification of 580×. Neutrophils were marked with myeloperoxidase antibody, macrophages with Mac-3, dendritic cells with fascin, B-lymphocytes with B220, CD4+ T-cells with CD4+ antibody, and CD8+T-cells with CD8-α. The significance of the differences was calculated using one-way analysis of variance. Results Chronic smoke exposure increased neutrophil VV by 97%, macrophage by 107%, dendritic cell by 217%, B-lymphocyte by 436%, CD4+ by 524%, and CD8+ by 417%. The higher dose of roflumilast prevented the increase in neutrophil VV by 78%, macrophage by 82%, dendritic cell by 48%, B-lymphocyte by 100%, CD4+ by 98% and CD8+ VV by 88%. The lower dose of roflumilast did not prevent the increase in neutrophil, macrophage and B-cell VV but prevented dendritic cells by 42%, CD4+ by 55%, and CD8+ by 91%. Conclusion These results indicate (i) chronic exposure to cigarette smoke in mice results in a significant recruitment into the lung of inflammatory cells of both the innate and adaptive immune system; (ii) roflumilast at the higher dose exerts a protective effect against the recruitment of all these cells and at the lower dose against the recruitment of dendritic cells and T-lymphocytes; (iii) these findings underline the role of innate immunity in the development of pulmonary emphysema and (iiii) support previous results indicating that the inflammatory cells of the adaptive immune system do not play a central role in the development of cigarette smoke induced emphysema in mice.

Từ khóa


Tài liệu tham khảo

Fabbri L, Pauwels RA, Hurd SS: Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease: GOLD executive summary updated 2003. J COPD. 2004, 1: 105-141.

Saetta M, Turato G, Lupi F, Fabbri LM: Inflammation in the pathogenesis of chronic obstructive pulmonary disease. Chronic Obstructive Lung Disease. Edited by: Voelkel NF, MacNee W. 2002, Hamilton/London: BC Decker Inc, 114-126.

Culpitt SV, Maziak W, Loukidis S, Nightingale JA, Matthews JL, Barnes PJ: Effect of high dose inhaled steroid on cells, cytokines, and proteases in induced sputum in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999, 160: 1635-1639.

Ito K, Lim S, Caramori G, Chung KF, Barnes PJ, Adcock IM: Cigarette smoking reduces histone deacetylase 2 expression, enhances cytokine expression, and inhibits glucocorticoid action in alveolar macrophages. FASEB. 2001, 15: 1100-1102.

McIvor RA: Future options for disease intervention: important advances in phosphodiesterase 4 inhibitors. Eur Respir Rev. 2007, 16: 105-112.

Martorana PA, Beume R, Lucattelli M, Wollin , Lungarella G: Roflumilast fully prevents emphysema in mice chronically exposed to cigarette smoke. Am J Respir Crit Care Med. 2005, 172: 848-853. 10.1164/rccm.200411-1549OC.

Wright JL, Kerstjens HAM, Timens W: What is new in chronic obstructive pulmonary disease?. Europ Respir Mon. 2007, 39: 153-169.

Barnes PJ, Shapiro SD, Pauwels RA: Chronic obstructive pulmonary disease: molecular and cellular mechanisms. Eur Respir J. 2003, 22: 672-688.

Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, Buzatu L, Chemiack RM, Rogers RM, Sciurba FC, Coxon HO, Pare PD: The nature of small airway obstruction in chronic obstructive pulmonary disease. N Engl J Med. 2004, 350: 2645-2653. 10.1056/NEJMoa032158.

Mosialos G, Birkenbach M, Ayehunie S, Matsumura F, Pinkus GS, Kieff E, Langhoff E: Circulating human dendritic cells differentially express high levels of a 55-kd actin-bundling protein. Am J Pathol. 1996, 148: 593-600.

Al-Alwan MM, Rowden G, Lee TD, West KA: Fascin is involved in the antigen presentation activity of mature dendritic cells. J Immunol. 2001, 166: 338-345.

Geyeregger R, Zeyda M, Bauer W, Kriehuber E, Säemann MD, Zlabinger GJ, Maurer D, Stulnig TM: Liver × receptors regulated dendritic cell phenotype and function through blocked induction of the action-bundling protein fascin. Blood. 2007, 109: 4288-4294. 10.1182/blood-2006-08-043422.

Meshi B, Vitalis TZ, Ionescu D, Elliott M, Liu C, Wang X-D, Hayashi S, Hogg JC: Emphysematous lung destruction by cigarette smoke. The effect of latent adenoviral infection on the lung inflammatory response. Am J RespirCell Mol Biol. 2002, 26: 52-57.

Foronjy RF, Mirochnitchenko O, Propokenko O, Lemaitre V, Jia Y, Inouye M, Okada Y, D'Armiento JM: Superoxide dismutase expression attenuates cigarette smoke- or elastase-generated emphysema in mice. Am J Respir Crit Care Med. 2006, 173: 623-631. 10.1164/rccm.200506-850OC.

D'hulst AI, Vermaelen KY, Brusselle GG, Joos GF, Pauwels RA: Time course of cigarette smoke-induced pulmonary inflammation in mice. Eur Respir J. 2005, 26: 204-213. 10.1183/09031936.05.00095204.

D'hulst AI, Bracke KR, Maes T, De Bleeker JL, Pauwels RA, Joss GF, Brusselle GG: Role of tumor necrosis factor-α receptor p75 in cigarette smoke-induced pulmonary inflammation and emphysema. Eur Respir J. 2006, 28: 102-112. 10.1183/09031936.06.00059305.

Finkelstein R, Fraser RS, Ghezzo H, Cosio MG: Alveolar inflammation and its relation to emphysema in smokers. Am J Respir Crit Care Med. 1995, 152: 1666-1672.

Selby C, MacNee W: Factors affecting neutrophil transit during acute pulmonary inflammation: minireview. Exp Lung Res. 1993, 19: 407-428. 10.3109/01902149309064355.

MacNee W: Pathogenesis of chronic obstructive pulmonary disease. Proc Am Thor Soc. 2005, 2: 258-266. 10.1513/pats.200504-045SR.

Zeid NA, Muller HK: Tobacco smoke induced lung granulomas and tumors: association with pulmonary Langerhans cells. Pathology. 1995, 27: 247-254. 10.1080/00313029500169063.

Brake K, Cataldo D, Maes T, Gueders M, Noel A, Foidart JM, Brusselle G, Pauwels RA: Matrix metalloproteinase-12 and cathepsin D expression in pulmonary macrophages and dendritic cells of cigarette smoke-exposed mice. Int Arch Allergy Immunol. 2005, 138: 169-179. 10.1159/000088439.

Maeno T, Houghton AM, Quintero PA, Grumelli S, Owen CA, Shapiro SD: CD8+ T Cells are required for inflammation and destruction in cigarette smoke-induced emphysema in mice. J Immunol. 2007, 178: 8090-8096.

Strate van der BW, Postma DS, Brandsma CA, Melgert BN, Luinge MA, Geerlings M, Hylkema MN, Berg van der A, Timens W, Kerstjens HA: Cigarette smoke induced emphysema: a role for the B cell?. Am J Respir Crit Care Med. 2006, 173: 751-758. 10.1164/rccm.200504-594OC.

Hogg JC: Bronchiolitis in chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2006, 3: 489-493. 10.1513/pats.200603-065MS.

Lambrecht BN, Hammad H: Taking our breath away: dendritic cells in the pathogenesis of asthma. Nat Rev Immunol. 2003, 3: 994-1003. 10.1038/nri1249.

Augusti A, MacNee W, Donaldson K, Cosio M: Hypothesis: does COPD have an autoimmune component?. Thorax. 2003, 58: 832-834. 10.1136/thorax.58.10.832.

Demedts IK, Brake KR, Van Pottelberge G, Testelmans D, Verleden GM, Vermassen FE, Joos GF, Brusselle GG: Accumulation of dendritic cells and increased CCL20 levels in the airways of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2007, 175: 998-1005. 10.1164/rccm.200608-1113OC.

Saetta M, Di Stefano A, Turato G, Facchini FM, Corbino L, Mapp CE, Maestrelli P, Ciaccia A, Fabbri LM: CD8+ T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998, 157: 822-826.

Hogg JC: Pathophysiology of airflow limitation in chronic obstructive pulmonary disease. Lancet. 2004, 364: 709-721. 10.1016/S0140-6736(04)16900-6.

D'hulst AI, Maes T, Bracke KR, Demedts IK, Toumoy KG, Joos GF, Brusselle GG: Cigarette smoke-induced pulmonary emphysema in scid-mice. Is the acquired immune system required?. Respir Res. 2005, 6: 147-159. 10.1186/1465-9921-6-147.

Robbins CS, Dawe DE, Goncharova SI, Pouladi MA, Drannik AG, Swirski FK, Cox G, Stämpfli MR: Cigarette smoke decreases pulmonary dendritic cells and impacts antiviral immune responsiveness. Am J Respir Cell Mol Biol. 2004, 30: 202-211. 10.1165/rcmb.2003-0259OC.

Thông tin
Thông tin xuất bản

Springer Science and Business Media LLC

Thông tin tác giả